v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Treasury Stock, at Cost
Beginning balance (in shares) at Dec. 31, 2024   232.2        
Beginning balance at Dec. 31, 2024 $ (1,004.2) $ 2.3 $ 2,682.8 $ 24.1 $ (3,682.4) $ (31.0)
Beginning balance (in shares) at Dec. 31, 2024           3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options and release of stock awards (in shares)   8.2        
Exercise of stock options and release of stock awards 0.0 $ 0.1 (0.1)      
Share-based compensation expense for equity classified awards 7.6   7.6      
Net (loss) income (71.5)       (71.5)  
Other comprehensive loss (5.0)     (5.0)    
Ending balance (in shares) at Mar. 31, 2025   240.4        
Ending balance at Mar. 31, 2025 $ (1,073.1) $ 2.4 2,690.3 19.1 (3,753.9) $ (31.0)
Ending balance (in shares) at Mar. 31, 2025           3.1
Beginning balance (in shares) at Dec. 31, 2025 245.3 248.4        
Beginning balance at Dec. 31, 2025 $ (1,219.5) $ 2.5 2,709.7 7.5 (3,908.2) $ (31.0)
Beginning balance (in shares) at Dec. 31, 2025 3.1         3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options and release of stock awards (in shares)   3.8        
Exercise of stock options and release of stock awards $ 0.0          
Share-based compensation expense for equity classified awards 3.8   3.8      
Net (loss) income 8.3       8.3  
Other comprehensive loss $ (9.3)     (9.3)    
Ending balance (in shares) at Mar. 31, 2026 249.1 252.2        
Ending balance at Mar. 31, 2026 $ (1,216.7) $ 2.5 $ 2,713.5 $ (1.8) $ (3,899.9) $ (31.0)
Ending balance (in shares) at Mar. 31, 2026 3.1         3.1